| Community Family Physicians, Pc | |
|
1724 W Plymouth St Bremen IN 46506-1940 | |
| (574) 546-3045 | |
| (575) 546-2716 |
| Full Name | Community Family Physicians, Pc |
|---|---|
| Speciality | Family Medicine |
| Location | 1724 W Plymouth St, Bremen, Indiana |
| Authorized Official Name and Position | Barbara J Jones (OFFICE MANAGER) |
| Authorized Official Contact | 5745463045 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Community Family Physicians, Pc 1724 W Plymouth St Bremen IN 46506-1940 Ph: (574) 546-3045 | Community Family Physicians, Pc 1724 W Plymouth St Bremen IN 46506-1940 Ph: (574) 546-3045 |
| NPI Number | 1033326814 |
|---|---|
| Provider Enumeration Date | 05/17/2007 |
| Last Update Date | 08/24/2010 |
| Medicare PECOS PAC ID | 8527031947 |
|---|---|
| Medicare Enrollment ID | O20040814000144 |
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033326814 | NPI | - | NPPES |
| 200441950A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Paul R Gettinger |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891791810 PECOS PAC ID: 6800874777 Enrollment ID: I20040708001047 |
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
| Provider Name | Michael R Mcclaid |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1003831207 PECOS PAC ID: 1456351600 Enrollment ID: I20070111000386 |
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
| Provider Name | David M Rosentrater |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1114923125 PECOS PAC ID: 5193857266 Enrollment ID: I20100726000338 |
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
| Provider Name | Laura A Both |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1356564447 PECOS PAC ID: 3173847720 Enrollment ID: I20150130001194 |
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
| Provider Name | Jessica L Laorden |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1366785750 PECOS PAC ID: 4981989472 Enrollment ID: I20220810001352 |
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
News Archive
A well-known drug used to treat hyperactive children boosts the potency of another drug that reduces Parkinson's disease symptoms, an Oregon Health & Science University study has found.
In this study, researchers from the University of Surrey, in collaboration with groups in South Africa, Brazil, Colombia and the USA, examined the sleeping patterns of people from two neighboring communities in Mozambique – the small electrified urban town Milange and the non-electrified rural community Tengua.
The Parenteral Drug Association (PDA) today launched one of two surveys on Quality Culture Metrics as part of its continuing program to evaluate quality metrics that can inform the regulator's risk-based inspection programs.
A new paper by researchers from the USA and China and published on the preprint server bioRxiv in July 2020 discusses a new drug based on the catalase enzyme, which could play a vital part in reducing the inflammation associated with progressive and severe COVID-19 disease.
› Verified 6 days ago
Elkhart Clinic, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1020 High Rd, Bremen, IN 46506 Phone: 574-296-3200 | |
Michiana Concierge Family Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1217 W Plymouth St, Bremen, IN 46506 Phone: 574-546-0654 Fax: 888-815-1434 | |
Aims-med, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 417 S Whitlock St, Bremen, IN 46506 Phone: 574-546-0330 Fax: 574-747-8650 | |
Beacon Medical Group Bremen Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1144 W Plymouth St, Bremen, IN 46506 Phone: 574-546-5363 Fax: 574-546-2575 |